Recommendations made by the PBAC - August 2017

3 November 2017 - Additional recommendations made by the PBAC in August 2017 relating to the listing of medicines on ...

Read more →

ICR responds to Government report produced following Accelerated Access Review

 3 November 2017 - The Institute of Cancer Research, London, today responds to the Government’s announcement of a new, fast-track ...

Read more →

NHS patients to get faster access to 'breakthrough' medicines

3 November 2017 - Drug firms will be offered a fast-track route to get “breakthrough” medicines to NHS patients up ...

Read more →

Final NICE nod for Sanofi’s Kevzara

2 November 2017 - The National Institute for Health and Care Excellence has issued final guidance backing Sanofi’s Kevzara as ...

Read more →

NICE back Roche’s Tecentriq for CDF

1 November 2017 - The National Institute for Health and Care Excellence is recommending Roche’s Tecentriq for use within the ...

Read more →

Drug giants threaten NHS with legal action over cheaper drug that could save 84 million pounds a year

1 November 2017 - Using cheaper version of drug effective against blindness is preferable to cost-cutting measures such as rationing, say ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2017 update

1 November 2017 - The November 2017 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Drug firms warn Ottawa against ‘crippling’ price cuts

31 October 2017 - Canada's brand-name pharmaceutical companies are pushing back against a plan to overhaul Canada's drug-pricing regulator, saying ...

Read more →

Australians buying 'useless' health insurance, AMA head says

31 October 2017 - Dr Michael Gannon says people should not need medical training to understand what insurance products cover. ...

Read more →

Health system can't work without insurers

31 October 2017 - Private insurers insist they have become an essential part of the health system and it would ...

Read more →

Private health insurers under pressure to limit premium rises and be more transparent

31 October 2017 - Private health insurers are under pressure to limit their annual fee increases to the Consumer Price ...

Read more →

Fund for next generation medicines investigated

1 November 2017 - A fund to give Kiwis quicker access to new-generation medicines will be investigated by the Government, ...

Read more →

New Zealand Pharmaceutical Schedule - 1 November 2017

1 November 2017 - The November 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Proposal to widen access to zoledronic acid for early breast cancer

31 October 2017 - PHARMAC proposes to widen funded access to zoledronic to include adjuvant use in post-menopausal women with ...

Read more →

Patient centred care is missing in action in Australia

30 October 2017 - The success of modern medicine is popularly seen in terms of hospitals and life-saving surgery.  ...

Read more →